Clinical Trial Update: Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating total neoadjuvant chemotherapy for 6 cycles versus 3 cycles in partial responders with epithelial ovarian cancer; the study status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Assiut University | Conditions: Stage III and IV Ovarian Cancer | Phase 3 | Status: NOT_YET_RECRUITING